Is Evolus Inc (NASDAQ: EOLS) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

EOLS belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Evolus Inc is $784.55M. A total of 0.62 million shares were traded on the day, compared to an average of 630.57K shares.

In the most recent transaction, Beaver Sandra sold 3,276 shares of EOLS for 14.98 per share on Sep 06 ’24. After the transaction, the Chief Financial Officer now owns 148,502 company shares. In a previous transaction on Aug 30 ’24, Yamagishi-Dressler Tomoko sold 5,631 shares at 15.85 per share. EOLS shares that Chief Marketing Officer owns now total 82,375.

Among the insiders who sold shares, MOATAZEDI DAVID disposed of 175,940 shares on Jun 06 ’24 at a per-share price of $12.59. This resulted in the insider holding 533,349 shares of EOLS after the transaction. In another insider transaction, MOATAZEDI DAVID sold 155,278 shares at $12.92 per share on Jun 05 ’24. Company shares held by the insider now total 533,349.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EOLS has a high of $17.82 and a low of $9.24.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EOLS’s latest balance sheet shows that the firm has $146.26M in Cash & Short Term Investments as of fiscal 2021. There were $74.74M in debt and $57.66M in liabilities at the time. Its Book Value Per Share was $0.09, while its Total Shareholder’s Equity was $81.88M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EOLS is Buy with a score of 4.86.

Most Popular

Related Posts